Genetic susceptibility to the respiratory effects of air pollution
- 1School of Medicine, The University of Queensland, The Prince Charles Hospital, Brisbane, Australia
- 2Department of Thoracic Medicine, The Prince Charles Hospital, Brisbane, Australia
- 3Infection, Inflammation and Repair Division, University of Southampton, Southampton, UK
- 4Human Genetics Division School of Medicine, University of Southampton, Southampton, UK
- Correspondence to Dr I Yang, Department of Thoracic Medicine, The Prince Charles Hospital, Rode Road, Chermside, Brisbane QLD 4032, Australia;
- Received 8 February 2007
- Accepted 9 May 2007
There is large variation between individuals in their response to air pollutants. This review summarises the existing evidence that genetic factors influence the mechanisms of lung injury caused by air pollutants. Genetic association studies have compared the adverse effects of air pollutants between subjects with specific genotypes in biologically relevant genes. In human studies of ozone exposure, polymorphisms in oxidative stress genes (NQO1, GSTM1, GSTP1) modify respiratory symptoms, lung function, biomarkers and risk of asthma. Inflammatory gene polymorphisms (TNF) influence the lung function response to ozone, and the effect of different levels of ozone on the development of asthma. Polymorphisms in oxidative stress genes (GSTM1, GSTP1) alter the response to combined exposure to ragweed pollen and diesel exhaust particles. Importantly, polymorphisms in an oxidative stress gene (GSTM1) have predicted patients with asthma who benefit from antioxidant supplementation in Mexico City, which has chronically high ozone exposure. Genetic linkage studies of families have not been feasible for studying the effects of air pollution in humans, but some progress has been made with pedigrees of specially bred mice, in identifying chromosomal regions linked to effects of ozone or particles. A high priority now, in addition to avoiding exposure in the most susceptible people, is to clearly identify the most effective and safe chemopreventive agents for individuals who are genetically susceptible to the adverse effects of air pollution (eg, antioxidants to be taken during high ozone levels).
Funding IAY, KMF and PVZ were supported by the National Health and Medical Research Council (Australia). STH is a Medical Research Council (UK) Professor of Immunopharmacology. JWH was supported by the Medical Research Council (UK), The British Lung Foundation, Asthma UK and the Asthma, Allergy & Inflammation Research Charity.
Competing interests None.
This is a reprint of a paper that appeared in Thorax, June 2008, volume 63, pages 555–63. Reproduced with kind permission of the author and publisher.